Stock Track | Zai Lab Plummets 5.04% Amid Broader Biomedical Sector Decline in Hong Kong

Stock Track

Oct 13

Zai Lab (09688.HK) experienced a significant downturn in Monday's trading session, with its stock plummeting 5.04% during intraday trading. This sharp decline reflects the broader weakness observed in the Hong Kong biomedical sector.

The fall in Zai Lab's stock price is part of a larger trend affecting biomedical stocks in the Hong Kong market. The sector as a whole faced downward pressure, with several key players seeing substantial declines in their share prices.

Among the affected companies, Junshi Biosciences led the decline with an 8% drop, followed by WuXi AppTec falling 6%. Zai Lab and WuXi Biologics both saw 5% decreases, while Tigermed experienced a 4% decline. This widespread downturn suggests broader market factors or sector-specific concerns affecting investor sentiment towards biomedical stocks in the region.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1140101623"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140101623\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140101623?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-13 11:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140101623","market":"sg","top_or_hot":-1,"title":"Stock Track | Zai Lab Plummets 5.04% Amid Broader Biomedical Sector Decline in Hong Kong","media":"Stock Track","content":"<p>Zai Lab (09688.HK) experienced a significant downturn in Monday's trading session, with its stock plummeting 5.04% during intraday trading. This sharp decline reflects the broader weakness observed in the Hong Kong biomedical sector.</p>\n\n<p>The fall in Zai Lab's stock price is part of a larger trend affecting biomedical stocks in the Hong Kong market. The sector as a whole faced downward pressure, with several key players seeing substantial declines in their share prices.</p>\n\n<p>Among the affected companies, Junshi Biosciences led the decline with an 8% drop, followed by WuXi AppTec falling 6%. Zai Lab and WuXi Biologics both saw 5% decreases, while Tigermed experienced a 4% decline. This widespread downturn suggests broader market factors or sector-specific concerns affecting investor sentiment towards biomedical stocks in the region.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Zai Lab Plummets 5.04% Amid Broader Biomedical Sector Decline in Hong Kong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Zai Lab Plummets 5.04% Amid Broader Biomedical Sector Decline in Hong Kong\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-13 11:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zai Lab (09688.HK) experienced a significant downturn in Monday's trading session, with its stock plummeting 5.04% during intraday trading. This sharp decline reflects the broader weakness observed in the Hong Kong biomedical sector.</p>\n\n<p>The fall in Zai Lab's stock price is part of a larger trend affecting biomedical stocks in the Hong Kong market. The sector as a whole faced downward pressure, with several key players seeing substantial declines in their share prices.</p>\n\n<p>Among the affected companies, Junshi Biosciences led the decline with an 8% drop, followed by WuXi AppTec falling 6%. Zai Lab and WuXi Biologics both saw 5% decreases, while Tigermed experienced a 4% decline. This widespread downturn suggests broader market factors or sector-specific concerns affecting investor sentiment towards biomedical stocks in the region.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09688","symbol_name":"再鼎医药","start_time":0,"source_url":"","article_id":"1140101623","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140101623","pubTimestamp":1760326345,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Zai Lab (09688.HK) experienced a significant downturn in Monday's trading session, with its stock plummeting 5.04% during intraday trading. This sharp decline reflects the broader weakness observed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09688":"再鼎医药"},"translate_title":"个股轨迹|再鼎医药大跌5.04%香港生物医药板块下跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09688":1},"content_text":"Zai Lab (09688.HK) experienced a significant downturn in Monday's trading session, with its stock plummeting 5.04% during intraday trading. This sharp decline reflects the broader weakness observed in the Hong Kong biomedical sector.\nThe fall in Zai Lab's stock price is part of a larger trend affecting biomedical stocks in the Hong Kong market. The sector as a whole faced downward pressure, with several key players seeing substantial declines in their share prices.\nAmong the affected companies, Junshi Biosciences led the decline with an 8% drop, followed by WuXi AppTec falling 6%. Zai Lab and WuXi Biologics both saw 5% decreases, while Tigermed experienced a 4% decline. This widespread downturn suggests broader market factors or sector-specific concerns affecting investor sentiment towards biomedical stocks in the region.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}